Food and Drug Administration (Simple English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Food and Drug Administration" in Simple English language version.

refsWebsite

Global rank Simple English rank

2^nd place

3^rd place

5^th place

5^th place

3semanticscholar.org

11^th place

9^th place

447^th place

1,594^th place

4^th place

6^th place

1webcitation.org

24^th place

15^th place

1,425^th place

2,448^th place

222^nd place

243^rd place

degruyter.com

"Chapter 1. Original Intent". The Supreme Court and Religion in American Life, Vol. 2. Princeton University Press. 2009-01-10. pp. 3–21. doi:10.1515/9781400826261.3. ISBN 978-1-4008-2626-1.

doi.org

doi.org

Huang, Yen-Chun; Lee, Hui-Chun; Lin, Yun-Lian; Tsai, Chia-Fen; Cheng, Hwei-Fang (2018-07-03). "Identification of a new type tadalafil analogue in a supplement product". Food Additives & Contaminants: Part A. 35 (7): 1233–1237. doi:10.1080/19440049.2018.1459052. ISSN 1944-0049. PMID 29601254. S2CID 4504685.
"Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug". Case Medical Research. 2018-06-28. doi:10.31525/fda2-ucm612193.htm. ISSN 2643-4652. S2CID 240427622.
"Chapter 1. Original Intent". The Supreme Court and Religion in American Life, Vol. 2. Princeton University Press. 2009-01-10. pp. 3–21. doi:10.1515/9781400826261.3. ISBN 978-1-4008-2626-1.
Temple, Robert (2002). "Policy developments in regulatory approval". Statistics in Medicine. 21 (19): 2939–2948. doi:10.1002/sim.1298. ISSN 1097-0258. PMID 12325110. S2CID 24779317.

dx.doi.org

"Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug". Case Medical Research. 2018-06-28. doi:10.31525/fda2-ucm612193.htm. ISSN 2643-4652. S2CID 240427622.

fda.gov

"FDA 1906". US FDA. Archived from the original on 2012-08-06. Retrieved 2010-09-11.
"Commissioner of Food and Drugs". US FDA. Retrieved 2010-09-11.

nih.gov

pubmed.ncbi.nlm.nih.gov

Huang, Yen-Chun; Lee, Hui-Chun; Lin, Yun-Lian; Tsai, Chia-Fen; Cheng, Hwei-Fang (2018-07-03). "Identification of a new type tadalafil analogue in a supplement product". Food Additives & Contaminants: Part A. 35 (7): 1233–1237. doi:10.1080/19440049.2018.1459052. ISSN 1944-0049. PMID 29601254. S2CID 4504685.
Temple, Robert (2002). "Policy developments in regulatory approval". Statistics in Medicine. 21 (19): 2939–2948. doi:10.1002/sim.1298. ISSN 1097-0258. PMID 12325110. S2CID 24779317.

semanticscholar.org

api.semanticscholar.org

Huang, Yen-Chun; Lee, Hui-Chun; Lin, Yun-Lian; Tsai, Chia-Fen; Cheng, Hwei-Fang (2018-07-03). "Identification of a new type tadalafil analogue in a supplement product". Food Additives & Contaminants: Part A. 35 (7): 1233–1237. doi:10.1080/19440049.2018.1459052. ISSN 1944-0049. PMID 29601254. S2CID 4504685.
"Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug". Case Medical Research. 2018-06-28. doi:10.31525/fda2-ucm612193.htm. ISSN 2643-4652. S2CID 240427622.
Temple, Robert (2002). "Policy developments in regulatory approval". Statistics in Medicine. 21 (19): 2939–2948. doi:10.1002/sim.1298. ISSN 1097-0258. PMID 12325110. S2CID 24779317.

webcitation.org

"FDA 1906". US FDA. Archived from the original on 2012-08-06. Retrieved 2010-09-11.

wiley.com

onlinelibrary.wiley.com

Temple, Robert (2002). "Policy developments in regulatory approval". Statistics in Medicine. 21 (19): 2939–2948. doi:10.1002/sim.1298. ISSN 1097-0258. PMID 12325110. S2CID 24779317.

worldcat.org

Huang, Yen-Chun; Lee, Hui-Chun; Lin, Yun-Lian; Tsai, Chia-Fen; Cheng, Hwei-Fang (2018-07-03). "Identification of a new type tadalafil analogue in a supplement product". Food Additives & Contaminants: Part A. 35 (7): 1233–1237. doi:10.1080/19440049.2018.1459052. ISSN 1944-0049. PMID 29601254. S2CID 4504685.
"Statement from FDA Commissioner Scott Gottlieb, M.D., on agency's continued efforts relating to compounded drugs for patients who cannot use an FDA-approved drug". Case Medical Research. 2018-06-28. doi:10.31525/fda2-ucm612193.htm. ISSN 2643-4652. S2CID 240427622.
Temple, Robert (2002). "Policy developments in regulatory approval". Statistics in Medicine. 21 (19): 2939–2948. doi:10.1002/sim.1298. ISSN 1097-0258. PMID 12325110. S2CID 24779317.